Immunomodulatory therapeutic potential of mesenchymal stem cells in COVID-19 pathogenesis
Author:
Singh Kulwant,Kumar Alok
Reference84 articles.
1. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study;Yang;Lancet Respir Med,2020
2. Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention;Wu;JAMA - J Am Med Assoc,2020
3. Cell therapy strategies for COVID-19: current approaches and potential applications;Zaki;Sci Adv,2021
4. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up;Tajbakhsh;Expert Rev Anti-Infect Ther,2021
5. Multi-organ damage by covid-19: congestive (cardio-pulmonary) heart failure, and blood-heart barrier leakage;Tyagi;Mol Cell Biochem,2021